Shionogi & Co., Ltd. (4507)

Name: Shionogi & Co., Ltd. (4507) — historial de estados financieros
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Historial de ingresos, beneficios y flujo de caja según los estados financieros oficiales.

Healthcare · Wall Street (EE. UU.) · Última actualización: 2026-10-02

Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.

Cifras clave

Capitalización bursátil: JPY 2.37 trillion
Ingresos (ejercicio cerrado en 2026-03-31): JPY 499.7B
Beneficio neto: JPY 205.2B
Margen bruto: 83.5%
Margen neto: 41.1%

Ver gráficos interactivos y estados completos → Modelo de valoración (DCF) →

Cuenta de resultados anual

Cuenta de resultados	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Ingresos totales	JPY 499.7B	JPY 438.3B	JPY 435.1B	JPY 426.7B	—
Beneficio bruto	JPY 417.2B	JPY 374.4B	JPY 377.5B	JPY 364.4B	—
Ingresos operativos (EBIT)	JPY 166.7B	JPY 156.6B	JPY 153.3B	JPY 149.0B	—
Ingresos netos	JPY 205.2B	JPY 170.4B	JPY 162.0B	JPY 185.0B	—

Fuente: informes públicos de la empresa (SEC). Verifique en SEC EDGAR antes de confiar en cualquier cifra.

Balances, flujos de caja, datos trimestrales y ratios completos en el visor interactivo de 4507. /companies/us/4507

Empresas similares

La información de este sitio es solo educativa e informativa; no constituye asesoramiento de inversión. No se publican precios objetivo ni recomendaciones.

English version →Todas las acciones

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.